We will work closely with Teva to ensure access of this medicine for payers, healthcare professionals and patients in the U.S.,” she added.

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the “Investors ...